Opiant Pharmaceuticals, Inc.

Filter

År

Typ

Språk

Rensa

2023-02-07 22:01:00 Opiant Pharmaceuticals Announces CFIUS Approval for Proposed Acquisition by Indivior PLC 21,03 USD | +1,11%

2023-01-19 22:05:00 Opiant Pharmaceuticals Announces FDA Acceptance and Priority Review of NDA for OPNT003, Nasal Nalmefene, for Opioid Overdose 20,45 USD | +0,34%

2022-11-22 22:01:00 Opiant Pharmaceuticals Announces Completion of Rolling NDA Submission for OPNT003, Nasal Nalmefene, for Opioid Overdose 20,09 USD | +0,10%

2022-11-14 08:14:01 Opiant Pharmaceuticals Announces Third Quarter 2022 Financial Results 20,10 USD | +111,58%

2022-11-14 08:12:39 Indivior PLC to Acquire Opiant Pharmaceuticals 20,10 USD | +111,58%

2022-10-27 22:05:00 Opiant Pharmaceuticals to Report Third Quarter 2022 Financial Results and Host Conference Call and Webcast on November 14, 2022 9,75 USD | -0,20%

2022-10-06 14:01:00 Opiant Pharmaceuticals Announces Completion of Enrollment in Phase 2 Clinical Trial of OPNT002, Nasal Naltrexone, in Patients with Alcohol Use Disorder 10,95 USD | -1,08%

2022-08-22 22:05:00 Opiant Pharmaceuticals Announces Notice of Allowance for U.S. Patent with Claims Covering OPNT004 for the Treatment of Cannabinoid Hyperemesis Syndrome 12,08 USD | +1,94%

2022-08-11 22:05:00 Opiant Pharmaceuticals Announces Second Quarter and First Half 2022 Financial Results and Provides Corporate Update 12,58 USD | -4,77%

2022-08-08 22:05:00 Opiant Pharmaceuticals Announces Additional $2.1 Million Funding Under BARDA Contract for OPNT003, Nasal Nalmefene 11,90 USD | +0,51%

2022-08-01 22:05:00 Opiant Pharmaceuticals to Report Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 11, 2022 10,09 USD | -1,75%

2022-06-28 22:05:00 Opiant Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 12,04 USD | +2,64%

2022-06-08 22:05:00 Opiant Pharmaceuticals and Aptar Pharma Expand Long-Term Collaboration for the Manufacture of Unidose Nasal Spray for OPNT003, Nasal Nalmefene 12,14 USD | -5,16%

2022-05-20 22:05:00 Opiant Pharmaceuticals to Hold Virtual 2022 Annual Shareholder Meeting on Tuesday, June 14, 2022 at 9:00am PDT 14,01 USD | -3,71%

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Opiant Pharmaceuticals, Inc.

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden